International Journal of Emergency Medicine (Apr 2024)

Guanfacine poisoning resulting in transient ST-segment elevation: a case report

  • Ichiro Hirayama,
  • Yoshito Kamijo,
  • Hiroko Abe,
  • Minaho Nonaka,
  • Tetsuhiro Yano,
  • Mitsuru Ishii,
  • Yoshiteru Tominaga

DOI
https://doi.org/10.1186/s12245-024-00634-0
Journal volume & issue
Vol. 17, no. 1
pp. 1 – 4

Abstract

Read online

Abstract Background Guanfacine is an alpha-2 adrenergic agonist that decreases norepinephrine release and sympathetic outflow. With the increased use of guanfacine for attention-deficit hyperactivity disorder (ADHD), reports of guanfacine poisoning have also risen. Case presentation A 15-year-old male (height: 170 cm, weight: 48 kg), who was taking 2 mg/day of guanfacine for ADHD, was brought to our emergency department after ingesting 40 tablets of guanfacine due to poor exam results. He presented with impaired consciousness and sinus bradycardia on an electrocardiogram (ECG), leading to diagnosis of guanfacine poisoning. Gastric lavage (5 L) was performed, and activated charcoal was administered. Although his consciousness gradually recovered, he developed ST-segment elevation on the ECG. Despite the absence of chest pain and elevated myocardial enzymes, coronary artery stenosis was not observed on coronary artery computed tomography. As his blood guanfacine level decreased, his ECG returned to normal. Conclusions This case highlights the need for careful monitoring of guanfacine poisoning patients due to the potential for various cardiovascular events.

Keywords